Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

Codman Pumps for Metastatic Liver Cancer Discontinued

Monday, May 14, 2018
On April 25, The New York Times (NYT) reported that Codman pumps, manufactured by Cerenovus, are no longer being produced as of April 1, because of manufacturing issues. These implanted constant-flow infusion pumps were primarily used for intrahepatic chemotherapy for colorectal liver metastasis. In addition, the NYT reports that demand for the Codman pumps was low, at around 300 pumps a year in the US.

Fortunately, there are other ways to deliver possibly life-extending intrahepatic treatment than using a totally implanted pump. Hepatic arterial infusions can be done by using either a hepatic arterial port or a percutaneously placed catheter connected to an external pump.

Both the Codman implanted and external pump approaches have associated potential complications, so appropriate patient selection and comprehensive nursing monitoring and patient education are critical.

Nurses will need to continue to care for patients who have had Codman pumps implanted, be aware that they are no longer being manufactured, and in the future, deliver care to patients with arterial catheters connected to portable external infusion pumps.


Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.